Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia

Respirology

Volumn 18, Issue 2, 2013, Pages 291-296

  Serisier, David J ^a,b,c   Williams, Sophie ^d   Bowler, Simon D ^a,b,c  

^a MATER ADULT HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d Department of Psychophysiology   (Australia)

Author keywords

bacterial pneumonia; community acquired pneumonia; practice guideline; severity scoring system

Indexed keywords

ARTICLE; AUSTRALIA AND NEW ZEALAND; BLOOD PRESSURE; BREATHING RATE; COMMUNITY ACQUIRED PNEUMONIA; EMERGENCY CARE; HUMAN; MAJOR CLINICAL STUDY; PHYSICIAN; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALASIA; COMMUNITY-ACQUIRED INFECTIONS; DATA COLLECTION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PHYSICIANS; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; SPECIALIZATION;

EID: 84872958160     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02275.x     Document Type: Article

References (22)

1. Kochanek KD, Xu JQ, Murphy SL, et al,. Death: preliminary data for 2009. National Vital Statistics Reports, 59(4). National Centre for Health Statistics, Hyattsville, MD, 2011.
2. Welte T, Torres A, Nathwani D,. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 37: 71-9.
3. Australian Bureau of Statistics. 3303.0. Causes of Death 2009. 2011. [Accessed 13 Apr 2012.] Available from URL: http://www.abs.gov.au
4. Charles PG, Whitby M, Fuller A, et al,. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin. Infect. Dis. 2008; 46: 1513-21. (Pubitemid 351706731)
5. Fine MJ, Auble TE, Yealy DM, et al,. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997; 336: 243-50. (Pubitemid 27044625)
6. Neill A, Martin IR, Weir R, et al,. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-6. (Pubitemid 26360177)
7. Lim WS, van der Eerden MM, Laing R, et al,. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82. (Pubitemid 36560938)
8. Ewig S, Ruiz M, Mensa J, et al,. Severe community-acquired pneumonia. Assessment of severity criteria. Am. J. Respir. Crit. Care Med. 1998; 158: 1102-8. (Pubitemid 28489008)
9. Mandell L, Wunderink RG, Anzueto A, et al,. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (Suppl. 2): S27-72. (Pubitemid 46290553)
10. Espana PP, Capelastegui A, Gorordo I, et al,. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2006; 174: 1249-56. (Pubitemid 44924826)
11. Charles PG, Wolfe R, Whitby M, et al,. SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support for community-acquired pneumonia. Clin. Infect. Dis. 2008; 47: 375-84. (Pubitemid 352009359)
12. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 13. Therapeutic Guidelines Limited, Melbourne, 2008.
13. Serisier DJ, Bowler SD,. Effect of a simple educational intervention on the hospital management of community acquired pneumonia. Respirology 2007; 12: 389-93. (Pubitemid 47164771)
14. Lee RW, Lindstrom ST,. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia. Respirology 2007; 12: 754-8. (Pubitemid 47414877)
15. Karmakar G, Wilsher M,. Use of the 'CURB 65' score in hospital practice. Intern. Med. J. 2010; 40: 828-32.
16. Chalmers JD, Singanayagam A, Akram AR, et al,. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010; 65: 878-85.
17. Renaud B, Santin A, Coma E, et al,. Association between timing of intensive care unit admissions and outcomes for emergency department patients with community-acquired pneumonia. Crit. Care Med. 2009; 37: 2867-74.
18. Singanayagam A, Chalmers JD, Hill AT,. Severity assessment in community-acquired pneumonia: A review. Q. J. Med. 2009; 102: 379-88.
19. Buising KL, Thursky KA, Black JF, et al,. Identifying severe community-acquired pneumonia in the emergency department: A simple clinical prediction tool. Emerg. Med. Australas. 2007; 19: 418-26. (Pubitemid 47547572)
20. Brown SM, Jones BE, Jephson AR, et al,. Validation of the Infectious Disease Society of America/ American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit. Care Med. 2009; 37: 3010-16.
21. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 14. Therapeutic Guidelines Limited, Melbourne, 2011.
22. Aujesky D, Auble TE, Yealy DM, et al,. Prospective comparison of three validated prediction rules for prognosis in community acquired pneumonia. Am. J. Med. 2005; 118: 384-92. (Pubitemid 40460997)